JHJelle C. L. Himmelreich

Jelle C. L. Himmelreich

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jelle C. L. Himmelreich has a total of 135 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Yield of Atrial Fibrillation Screening according to Methodology and Patient Characteristics: An Individual Participant Data Meta-Analysis of 34,165 Individuals Screened for Atrial Fibrillation within the AFFECT-EU/AF-SCREEN Collaboration

    by Lucas Y Xing, William F McIntyre, Johan Engdahl, Matthias Daniel Zink, Nikolaus Albert Helmut Marx, Emma Svennberg, Katrin Kemp Gudmundsdottir, Jelle C L Himmelreich, Giuseppe Boriani, Davide Antonio Mei, et al.

    Backgrounds and Aims: Atrial fibrillation (AF) screening may reduce adverse outcomes through early initiation of preventive treatment. However, more data are warranted to inform the yield of different screening strategies. This study aimed to evaluate how patient characteristics and screening methodologies influence screening yield. Methods: We conducted an individual participant data meta-analysis of 12 European and North American study cohorts, by using generalized linear mixed models with random intercept at study level. Results: In this meta-analysis of 34,165 participants screened for AF (age 73.4 ± 7.5 years and 53.5% female), the screening yield increased with more intensive approaches, ranging from 0.83% [95% confidence interval (CI): 0.24-2.87] in single-timepoint screening, to 5.06% [95% CI: 3.55-7.17] in intermittent (i.e. repeated single-timepoint) screening, 4.81% [95% CI: 3.79-6.08] in short-term continuous monitoring (≤30 days), and up to 30.39% [95% CI: 28.06-32.84] in long-term continuous monitoring (>30 days). Advanced age, male sex, hypertension, and heart failure (HF) were associated with detection. Significant interactions were observed between screening approach and age, sex, HF, CHADS2, and NT-proBNP. These risk factors had a stronger influence on AF detection with single-timepoint screening, compared with more intensive methods. Conclusions: In this meta-analysis, AF screening yield varied substantially by patient characteristics and screening approach. Advanced age, male sex, and HF were independently associated with greater AF detection, particularly in those having single-timepoint screening. Our findings support tailoring the screening approach to the individual target population in clinical practice. Further studies to assess clinical outcomes following screening are needed and underway.

  • Open Access

    Safety and efficiency of the HEART-GP strategy with point-of-care high-sensitivity troponin testing for acute chest pain in out-of-hours primary care: a prospective multicentre diagnostic accuracy study

    by Indra Melessen, Jelle C. L. Himmelreich, Amy Manten, Eric Moll van Charante, Ralf Harskamp

    Background: GPs are often the first clinicians to assess acute chest pain in gatekeeper healthcare systems, but usually with limited diagnostic support. They must distinguish conditions that can be managed safely in primary care from those requiring immediate hospital evaluation, particularly acute coronary syndrome (ACS), while avoiding unnecessary over-referral to already pressured emergency departments. We evaluated HEART-GP, a novel GP-led strategy combining structured clinical assessment, fingerstick point-of-care high-sensitivity troponin I testing, and ECG when available. Methods: We performed a prospective, multicentre, paired diagnostic accuracy study in four Dutch out-of-hours primary care centres implementing the HEART-GP strategy. Patients with acute non-traumatic chest pain and possible ACS according to the treating GP were enrolled from March 2023 to August 2025. Before troponin results were available, GPs recorded intended management, allowing paired comparison with unaided clinical judgement. The HEART-GP strategy recommended urgent referral for high clinical suspicion, troponin of >=4 ng/L, or ischaemic ECG. The primary outcome was adjudicated 6-week major adverse cardiovascular events (MACE). The study was registered as ISRCTN11954040 . Findings: Of 1104 patients who underwent HEART-GP, 917 were included. MACE occurred in 62 (6.8%) and myocardial infarction in 52 (5.7%). HEART-GP classified 478 (52.1%) as low risk. For MACE, sensitivity was 95.2% (95% CI 86.5-99.0) and negative predictive value was 99.4% (98.1-99.8); three MACE occurred in the low-risk group, with no cardiac deaths. For myocardial infarction, sensitivity was 98.1% (89.7-100) and negative predictive value was 99.8% (98.6-100). Compared with unaided GP judgement, HEART-GP improved sensitivity for MACE (95.2% vs 67.7%; p<0.001) and myocardial infarction (98.1% vs 67.3%; p<0.001), and reduced urgent referrals (439 [47.9%] vs 483 [52.7%]; p=0.042). Interpretation: HEART-GP showed high rule-out safety and may support GP diagnostic certainty and efficient referrals in patients with possible ACS. Implementation requires training, governance, safety-netting, and local pathways.

  • Open Access

    Marburg Heart Score and INTERCHEST score for telephone triage of acute chest pain: a prospective, diagnostic accuracy study in out-of-hours primary care

    by Amy Manten, Indra M B Melessen, Jelle C L Himmelreich, Eric P Moll van Charante, Ralf E Harskamp

    Objectives: To assess whether the Marburg Heart Score (MHS) and INTERCHEST score may improve telephone triage of chest pain by providing better diagnostic discrimination compared with the triage protocol from the Netherlands Triage Standard (NTS). Design: Prospective diagnostic accuracy study. Setting: Large regional out-of-hours primary care (OOH-PC) facility in Alkmaar, the Netherlands. Participants: A total of 1254 eligible patients contacted the OOH-PC facility (median age 56.0 years, 57.9% female) between December 2022 and May 2023. The study was completed and verbal informed consent obtained in 280 (22.3%) patients. Interventions: Triage assistants asked study questions in addition to the NTS protocol to complete the MHS and INTERCHEST score. Primary and secondary outcome measures: Discrimination (C-statistics) and diagnostic test properties (eg, sensitivity/specificity) were used; the reference standard was the occurrence of a major event (ie, composite of all-cause mortality, and urgent cardiovascular and non-cardiovascular conditions) or acute coronary syndrome (ACS) within 6 weeks. Results: A major event occurred in 36 patients (12.9%), including 13 (4.6%) ACS cases. For predicting major events, the MHS and INTERCHEST scores showed C-statistics of 0.67 (95% CI 0.57 to 0.77) and 0.64 (95% CI 0.54 to 0.74), respectively, compared with 0.62 (95% CI 0.53 to 0.71) for the NTS protocol. For ACS, C-statistics were 0.62 (95% CI 0.45 to 0.79), 0.59 (95% CI 0.43 to 0.75), and 0.62 (95% CI 0.49 to 0.75) for MHS, INTERCHEST and NTS, respectively. Regarding test characteristics, the MHS and INTERCHEST score showed higher point estimates for specificity (27.9% and 26.6%) vs the NTS (19.7%), but at the expense of lower sensitivity (88.9% and 86.1% versus 97.2%) for major events. For ACS, a similar pattern was observed (specificity 26.2% and 25.5% vs 18.4; sensitivity 84.6% and 84.6% vs 100.0%). Conclusions: Simple clinical decision rules (MHS and INTERCHEST) have comparable, modest discriminative ability and diagnostic properties compared with the current protocol for telephone triage of acute chest pain in Dutch OOH-PC. Trial registration number: Netherlands Trial Register (TRACE – NL-OMON20102).

  • Open Access

    SOLO study: A single-pill combination strategy in general practice to optimize blood pressure control in a multi-ethnic community

    by R.E. Harskamp, W.R. Naaktgeboren, J. Strijp, Sanne Smits, J.C.L. Himmelreich

    Background: Hypertension is a major modifiable risk factor for cardiovascular disease, yet blood pressure (BP) control remain suboptimal, particularly in socially disadvantaged communities. Guidelines recommend initiating single-pill combination (SPC) therapy to improve adherence and BP control, but uptake in primary care is limited. Objectives: To evaluate the SOLO care improvement project, promoting SPC initiation among general practitioners (GPs) in Amsterdam Zuidoost, a disadvantaged, multi-ethnic community in The Netherlands with a high hypertension burden. Methods: In a cluster quasi-randomized cluster design, adult hypertensive patients from nine general practices within one health facility were allocated to intervention (IC; n=5) or usual care (UC; n=4). Intervention practices received case-specific guidance on SPC therapy. Outcomes were SPC uptake, changes in systolic and diastolic BP (SBP and DBP), target BP achievement and cardiovascular events. Analyses used intention-to-treat adjusted regression and Cox models, with additional as-treated analysis among SPC users. Results: Among 438 patients (mean age 64.5±12.2 years; median follow-up of 367 days [213-467]), SPC initiation was higher in the IC than US (25.1% vs. 9.6%, p<0.001). SBP/DBP decreased by -15.7/-6.9 mmHg in the IC and -10.4/-4.6 mmHg in the UC. Target BP was more often achieved in the IC (57.3% vs. 48.1%; OR: 1.4, 95%CI:1.0-2.1). Among SPC users, SBP/DBP decreased by -22.4/-10.5 mmHg. Conclusion: Promoting SPC therapy improved blood pressure control, supporting local, targeted implementation as a pragmatic strategy to enhance hypertension management. Summary box, bullet points: - In the SOLO care improvement project, SPC initiation was increased and improved blood pressure control in routine primary care. - The real-world implementation and cluster-based comparison enhanced practical relevance and reduced contamination between practices. - Although conducted in a large community health center, generalizability cannot be assumed; the non-blinded, non-randomized design allows residual confounding.

  • Open Access

    The HEART-GP strategy for ruling out acute coronary syndrome in out-of-hours primary care: a diagnostic accuracy trial protocol

    by Indra M.B. Melessen, Jelle C.L. Himmelreich, Amy Manten, Edanur Sert, Simone van Den Bulk, Tobias N. Bonten, Martijn H. Rutten, Eric P. Moll van Charante, Ralf E. Harskamp

  • Open Access

    Patient experiences with a smartwatch 1L-ECG versus traditional Holter monitoring for ambulatory cardiac rhythm monitoring: a qualitative study

    by Evert P M Karregat, Pieter Vooijs, Eric Wierda, Ralf Harskamp, Wim Lucassen, Jelle C L Himmelreich, Eric P Moll van Charante

    Objective: To explore patients’ experiences and perspectives on using a direct-to-consumer smartwatch with single-lead electrocardiography (1L-ECG) for ambulatory rhythm diagnostics in primary care. Design: Qualitative study using semi-structured interviews and thematic analysis. Setting: Primary care patients referred for ambulatory rhythm monitoring in a diagnostic centre. Participant: Eighteen adults with paroxysmal palpitations, of whom nine were female patients (50%), aged 32–85 (median 66) years. Intervention: Participants simultaneously wore a smartwatch with 1L-ECG capability (Withings ScanWatch) and a conventional Holter monitor for 7 days. Outcome measures: Patient experiences and perceived barriers and facilitators to smartwatch use for rhythm monitoring, reported after the monitoring period. Results: Patients found the smartwatch more user-friendly and feasible than the Holter monitor. Difficulties included uncertainty about when to initiate recordings, challenges capturing brief episodes and anxiety triggered by automated algorithm outputs. Participants emphasised the importance of accessible healthcare support for interpretation and reassurance. Conclusions: This study shows that smartwatch-based 1L-ECG monitoring is feasible and acceptable for ambulatory rhythm diagnostics in primary care. Prior to routine implementation, it is crucial to address the identified challenges: particularly anxiety related to algorithm results, uncertainty about when to record and accessible clinician support.


  • Open Access

    The HEART-GP strategy for ruling out acute coronary syndrome in out-of-hours primary care: a diagnostic accuracy trial protocol

    by Indra M.B. Melessen, Jelle C. L. Himmelreich, Amy Manten, Edanur Sert, Simone van Den Bulk, Tobias N. Bonten, Martijn H. Rutten, Eric P. Moll van Charante, Ralf E. Harskamp

    Background: Acute coronary syndrome (ACS) is a life-threatening condition that must be rapidly identified to prevent morbidity and mortality. Differentiating ACS from benign conditions remains difficult in primary care settings due to non-specific and overlapping symptom profiles, and limited diagnostic resources. Current guidelines promote a low threshold for emergency department (ED) referral, resulting in referral rates of 40–70%. Despite this cautious approach, ACS cases are still missed, sometimes with serious consequences. The arrival of high-sensitivity troponin (hs-troponin) point-of-care testing (POCT) may enable safer, faster, and more efficient diagnosis in primary care settings. Methods and analysis: This multicenter prospective diagnostic accuracy trial evaluates the HEART-GP strategy , combining a single fingerstick hs-troponin test with clinical assessment and optional ECG. Adults (≥18 years) presenting with acute chest pain or discomfort to one of four participating Dutch OOH-PC centers are eligible. The primary outcome is the occurrence of major adverse cardiovascular events a composite of death, ACS, or urgent revascularization within six weeks. Diagnostic safety (sensitivity, negative predictive value) and efficiency (ED referral reduction) will be compared against standard care. Secondary analyses will assess the value of sex-specific cut-offs and integration with existing risk scores (HEART, INTERCHEST, Marburg Heart Score). Anticipated results: We anticipate that the HEART-GP strategy will demonstrate high diagnostic safety along with marked efficiency gains, with potential for reducing unnecessary ED referrals. If hs-POCT proves reliable, it could be implemented widely to improve the safety and efficiency of acute chest pain evaluation in pre-hospital care. Ethics and dissemination: The study was approved by the CCMO (CIV-NL-22-11-041231, 11-03-2022) and the Medical Research Ethics Committee (MREC) of the Amsterdam UMC (NL82428.000.22, 02-03-2023) and registered in the ISRCTN registry ( ISRCTN11954040 ). Results will be disseminated through peer-reviewed journals, academic conferences, and stakeholder engagement to inform future diagnostic pathways in primary care. Strengths and limitations of this study: Strengths: An innovative, pragmatic strategy for rapid rule-out of ACS High external validity due to prospective, multi-center, real-world OOH-primary care design Identification of the optimal strategy of various risk stratification approaches using hs-troponin testing Blinded, independent adjudication of clinical outcomes Limitations: Powered for the composite MACE, but not for the individual components: death, ACS, or urgent coronary revascularization Despite the use of a (delayed) reference standard, complete avoidance of possible verification bias cannot be achieved

  • Identifying rehabilitation needs as part of secondary prevention in individuals with atrial fibrillation—a Delphi consensus study

    by Caroline M Elnegaard, Signe S Risom, Britt Borregaard, Mickael Bech, Ditte Albrektsen, Jan Astrup, Ann Bovin, Bo Christensen, Jonathan David, Lien Desteghe, et al.

    Aims: This study aimed to establish general consensus on a systematic needs assessment model to determine eligibility for cardiac rehabilitation (CR) as part of secondary prevention in individuals with atrial fibrillation (AF). Specific objectives included identifying relevant needs assessment criteria and establishing consensus on referral criteria. Methods and results: A Delphi study was conducted following the ACCORD guidelines (ACcurate COnsensus Reporting Document) with participation of an international, multi-disciplinary expert panel including physicians, nurses, and other healthcare professionals, across primary and secondary care as well as academic research. The panel also included six people who had AF themselves. The Delphi process involved three iterative rounds of surveys and a video meeting to determine needs assessment criteria and facilitate consensus. Data collection included qualitative feedback and quantitative voting on proposed criteria. Sixty-nine experts participated. There was high agreement on the importance of the study, which identified 12 needs assessment criteria related to AF symptom burden, health-related quality of life, anxiety, medicine adherence, and various risk factors. Whilst there was agreement on the needs assessment model, experts noted that referral criteria should be flexible and tailored to local healthcare settings, emphasizing that each individual's situation is unique. Conclusion: This Delphi study established a needs assessment model that can be adapted to local contexts for individuals with AF. More research is needed to refine referral criteria and ensure effective implementation of individually tailored CR strategies.


  • Open Access

    Impact of abnormal ambulatory ECG findings when screening for atrial fibrillation in primary care: a qualitative study among participants of the PATCH-AF trial

    by Tessa Brik, Marilou S Niekel, Marieke A R Bak, Jelle C L Himmelreich, Ralf E Harskamp, Eric P Moll van Charante

    Background and aim European cardiovascular guidelines recommend systematic atrial fibrillation (AF) screening in community-dwelling high-risk patients. However, little is known about the impact of abnormal screening findings, including AF and non-AF incidental findings on the target population. This gap highlights the need to assess both the benefits and potential harms from patients’ perspectives to fully understand the impact of AF screening. Therefore, the aim of this study is to explore patients’ experiences with AF screening among those who received abnormal findings from ambulatory ECG monitoring. Design We conducted a qualitative study using semistructured interviews, analysed thematically. Participants in the PATCH-AF trial, based in Amsterdam primary care, were purposively sampled based on their screening results (AF or non-AF incidental findings), sex and socioeconomic status. Results We achieved data saturation after conducting 16 interviews (6 with interviewees diagnosed with AF and 10 with non-AF incidental findings). Participants had a median age of 76 (73–79) years, and 56% were male. Their experiences, whether positive or negative, fluctuated throughout the screening process and depended on their initial motivations for participation in AF screening (seeking extra health checks, finding explanations for pre-existing symptoms or contributing to medical research), expectations and perceived benefits from clarification, diagnostic workup or treatment. Influencing factors included the type of finding (AF or non-AF incidental finding), healthcare provider communication and individual characteristics such as age, socioeconomic status and medical history. Conclusion This qualitative study highlights both positive and negative AF screening experiences from the patients’ perspective. It underscores how patients’ motivations and expectations for participation, the type of ambulatory ECG finding and communication and follow-up by healthcare providers shape their overall experiences. Healthcare providers should be aware of these factors to optimise screening consultations. Clear guidelines on communicating abnormal ambulatory ECG findings, especially incidental findings, are warranted. Trial registeration number The Netherlands Trial Register (NTR) number NL9656.


  • Open Access

    Ultrasonography in General Practice: insights from an implementation study in a Low-income neighborhood of Amsterdam

    by Ralf E. Harskamp, Britt Soddemann Genaamd Keute, Constantijn Pleiter, Jelle C.L. Himmelreich

    Background Ultrasonography is increasingly being used in primary care settings, facilitated by technological advancements, reduced device-related costs, and improved access to training and support. It holds particular promise for underserved communities, where barriers such as co-pays or long waiting lists can limit access to diagnostic services. This study evaluates the impact of a primary care ultrasonography service in an underserved urban community. Methods We conducted a retrospective cohort study of consecutive patients who underwent ultrasonography between 2019-2024 at a large primary care center (n=7877 patients) in Amsterdam the Netherlands. The primary outcomes included the frequency, indications, and diagnostic outcomes. Secondary outcomes included diagnostic accuracy, changes in clinical decision-making, referral rates, and costs. Results A total of 394 patients were included, of whom 62.4% underwent abdominal ultrasonography, 31.7% gynecological ultrasonography, and 5.8% other types of ultrasounds. Ultrasonography yielded conclusive results in 83.5% of cases, and reduced secondary care referrals by 58.8%. The sensitivity and specificity for ultrasonographic abnormalities were 98.9% (95%CI: 94.2-99.9%) and 89.8% (95%CI: 85.3-93.4%), respectively. Conclusion Primary care ultrasonography enhances diagnostic efficiency and reduces unnecessary referrals in more than half of cases. Its use in underserved communities can improve healthcare access and help address system-related health disparities. Further research is needed to assess its cost-effectiveness and scalability.